News
Search EMA's news announcements
Megjegyzés a megjelenített nyelvhez
Ez az oldal nem érhető el az Ön által választott nyelven a weboldalon található gépi fordítási szolgáltatáson keresztül.
Az oldal az eredeti angol nyelvű változatban jelenik meg.
On 29 September 2026, we updated the search paths shown in your browser's address bar to make them easier to read and understand. As a result, links to search results that you previously bookmarked may no longer work. We advise you to carry out your search again.
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting

Eight new medicines recommended for approval; another 13 medicines recommended for extension of their therapeutic indications
Jascayd slowed loss of lung function in patients with idiopathic or progressive pulmonary fibrosis
Wegovy tablets offer an alternative to subcutaneous injections
Vijoice addresses an unmet medical need for patients with severe or life-threatening PIK3CA-related overgrowth spectrum (PROS) disorders
The European Medicines Agency's (EMA) office is closed from 18:00 on Friday 22 May until 08:30 on Tuesday 26 May

19 multinational clinical trials have been authorised in addition to the historical average; 40.5% of the total number of clinical trials recruit participants within 200 days

Risk for the general population currently considered very low by ECDC
The European Medicines Agency's (EMA) office is closed from 18:00 on Wednesday 13 May until 08:30 on Monday 18 May

Act to improve availability, production and supply of critical medicines in the European Union